J Clin Aesthet Dermatol. 2020;13(2):47–52 by Jagdish Sakhiya, MD; Dhruv Sakhiya, MBBS; Ravi Khambhati, MBBS, DVD; Mehul Patel, DNB, DVL; Piyush Darji, mD; Trusha Gajjar, DVD; Feral Daruwala, M. Pharm; and Nimish Dudhatra, MSc, CR Dr. J. Sakhiya and Drs. Khambhati, Patel, Darji, and Gajjar are with the Sakhiya Skin Clinic in Gujarat, India. Mrs.
J Clin Aesthet Dermatol. 2020;13(2):53–57 by Polytimi Sidiropoulou, MD; Stamatis Gregoriou, MD, PhD; Dimitris Rigopoulos, MD, PhD; and Georgios Kontochristopoulos, MD, PhD Drs. Sidiropoulou, Gregoriou and Rigopoulos are with the 1st Department of Dermatology-Venereology of the National and Kapodistrian University of Athens at Andreas Syggros Hospital for Cutaneous & Venereal Diseases in Athens, Greece. Dr.
J Clin Aesthet Dermatol. 2020;13(2):58–60 by Ankita Tuknayat, MBBS, MD; Mala Bhalla, MD; Amrit Kaur MBBS; and Shimona Garg, MD All authors are with the Department of Dermatology, Venereology and Leprosy, Government Medical College and Hospital in Chandigarh, India. FUNDING: No funding was provided for this study. DISCLOSURES: The authors have no conflicts of interest
J Clin Aesthet Dermatol. 2020;13(2):61–66 by Mukta Sachdev, MD; Keerthi Velugotla, DDVL; Sapna Revanker, MD; and Geetha Somasekhar, DO, DNB All authors are with MS Clinical Research in Bangalore, India. Drs. Sachdev and Velugotla are also with MS Skin Clinic in Bangalore, India. FUNDING: This study was funded by an educational grant from SkinGen International
Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.